AI summary · may contain errors
PDGF-BB and bFGF, but not VEGF-A, repress Kai1 (CD82) expression in murine pericyte-like cells via Src-linked DNMT promoter methylation and lysosomal degradation.
- Open access
Springer Nature · Oncology · ISSN 0950-9232, 1476-5594
Rebuilt
Newest first · last 60 days
AI summary · may contain errors
PDGF-BB and bFGF, but not VEGF-A, repress Kai1 (CD82) expression in murine pericyte-like cells via Src-linked DNMT promoter methylation and lysosomal degradation.
AI summary · may contain errors
B3GNT9 is significantly upregulated in glioblastoma tumor cells in the peritumoral brain zone (PBZ), and its high expression is linked to poor prognosis.
AI summary · may contain errors
Higher RHBDL2 expression is associated with chemoresistance and poor prognosis in patients with triple-negative breast cancer (TNBC), and RHBDL2 knockdown suppresses stemness and resistance in TNBC cells.
AI summary · may contain errors
ADORA1-FASN–palmitic acid metabolic reprogramming is linked to therapy-induced senescence and oxaliplatin resistance in colorectal cancer, with ADORA1 induced by oxaliplatin and enriched in chemoresistant patients.
AI summary · may contain errors
In human prostate tumors, PKA subunits show grade-dependent spatial redistribution—RIβ declines while PKAC shifts into proliferating Grade Group 4 cells—linked to stronger substrate phosphorylation.
AI summary · may contain errors
Chemoresponsive triple-negative breast cancer PDX models show distinct transcriptional trajectories that diverge within one week of chemotherapy, with early cytokine and apoptotic pathway activation absent in chemoresistant models.
Journals this month
Topics moving, week to 17 Nov 2026
By field